Efficacy of maternal screening and therapy in the prevention of chlamydia infection of the newborn

Julia McMillan, L. B. Weiner, H. V. Lamberson, J. H. Hagen, R. H. Aubry, R. W. Abdul-Karim, S. G. Sunderji, Anne P. Higgins

Research output: Contribution to journalArticle

Abstract

Routine cervical cultures for chlamydia were obtained during the third trimester of pregnancy to identify infected mothers whose infants may also be infected. The effectiveness of maternal erythromycin therapy in preventing disease due to chlamydia among infants born to these women was also assessed. Clinical outcome of treated mothers and infants was compared to that of untreated subjects. Of 1082 women who were cultured, 85 (7.8%) were positive for chlamydia. Erythromycin therapy was prescribed for 38 of these women. Nasopharyngeal/conjunctival chlamydia cultures were obtained from 16 infants of culture-positive, treated mothers and 21 infants of culture-positive, untreated mothers. None of the infants born to culture-positive, treated mothers developed infection with chlamydia, while five of 21 infants of untreated mothers (p

Original languageEnglish (US)
Pages (from-to)263-266
Number of pages4
JournalInfection
Volume13
Issue number6
DOIs
StatePublished - Nov 1985
Externally publishedYes

Fingerprint

Chlamydia Infections
Mothers
Newborn Infant
Chlamydia
Erythromycin
Therapeutics
Third Pregnancy Trimester

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology

Cite this

McMillan, J., Weiner, L. B., Lamberson, H. V., Hagen, J. H., Aubry, R. H., Abdul-Karim, R. W., ... Higgins, A. P. (1985). Efficacy of maternal screening and therapy in the prevention of chlamydia infection of the newborn. Infection, 13(6), 263-266. https://doi.org/10.1007/BF01645435

Efficacy of maternal screening and therapy in the prevention of chlamydia infection of the newborn. / McMillan, Julia; Weiner, L. B.; Lamberson, H. V.; Hagen, J. H.; Aubry, R. H.; Abdul-Karim, R. W.; Sunderji, S. G.; Higgins, Anne P.

In: Infection, Vol. 13, No. 6, 11.1985, p. 263-266.

Research output: Contribution to journalArticle

McMillan, J, Weiner, LB, Lamberson, HV, Hagen, JH, Aubry, RH, Abdul-Karim, RW, Sunderji, SG & Higgins, AP 1985, 'Efficacy of maternal screening and therapy in the prevention of chlamydia infection of the newborn', Infection, vol. 13, no. 6, pp. 263-266. https://doi.org/10.1007/BF01645435
McMillan, Julia ; Weiner, L. B. ; Lamberson, H. V. ; Hagen, J. H. ; Aubry, R. H. ; Abdul-Karim, R. W. ; Sunderji, S. G. ; Higgins, Anne P. / Efficacy of maternal screening and therapy in the prevention of chlamydia infection of the newborn. In: Infection. 1985 ; Vol. 13, No. 6. pp. 263-266.
@article{e1958e3359fb42398d5f5bfd63e6b1b9,
title = "Efficacy of maternal screening and therapy in the prevention of chlamydia infection of the newborn",
abstract = "Routine cervical cultures for chlamydia were obtained during the third trimester of pregnancy to identify infected mothers whose infants may also be infected. The effectiveness of maternal erythromycin therapy in preventing disease due to chlamydia among infants born to these women was also assessed. Clinical outcome of treated mothers and infants was compared to that of untreated subjects. Of 1082 women who were cultured, 85 (7.8{\%}) were positive for chlamydia. Erythromycin therapy was prescribed for 38 of these women. Nasopharyngeal/conjunctival chlamydia cultures were obtained from 16 infants of culture-positive, treated mothers and 21 infants of culture-positive, untreated mothers. None of the infants born to culture-positive, treated mothers developed infection with chlamydia, while five of 21 infants of untreated mothers (p",
author = "Julia McMillan and Weiner, {L. B.} and Lamberson, {H. V.} and Hagen, {J. H.} and Aubry, {R. H.} and Abdul-Karim, {R. W.} and Sunderji, {S. G.} and Higgins, {Anne P.}",
year = "1985",
month = "11",
doi = "10.1007/BF01645435",
language = "English (US)",
volume = "13",
pages = "263--266",
journal = "Infection, Supplement",
issn = "0300-8126",
publisher = "Urban und Vogel",
number = "6",

}

TY - JOUR

T1 - Efficacy of maternal screening and therapy in the prevention of chlamydia infection of the newborn

AU - McMillan, Julia

AU - Weiner, L. B.

AU - Lamberson, H. V.

AU - Hagen, J. H.

AU - Aubry, R. H.

AU - Abdul-Karim, R. W.

AU - Sunderji, S. G.

AU - Higgins, Anne P.

PY - 1985/11

Y1 - 1985/11

N2 - Routine cervical cultures for chlamydia were obtained during the third trimester of pregnancy to identify infected mothers whose infants may also be infected. The effectiveness of maternal erythromycin therapy in preventing disease due to chlamydia among infants born to these women was also assessed. Clinical outcome of treated mothers and infants was compared to that of untreated subjects. Of 1082 women who were cultured, 85 (7.8%) were positive for chlamydia. Erythromycin therapy was prescribed for 38 of these women. Nasopharyngeal/conjunctival chlamydia cultures were obtained from 16 infants of culture-positive, treated mothers and 21 infants of culture-positive, untreated mothers. None of the infants born to culture-positive, treated mothers developed infection with chlamydia, while five of 21 infants of untreated mothers (p

AB - Routine cervical cultures for chlamydia were obtained during the third trimester of pregnancy to identify infected mothers whose infants may also be infected. The effectiveness of maternal erythromycin therapy in preventing disease due to chlamydia among infants born to these women was also assessed. Clinical outcome of treated mothers and infants was compared to that of untreated subjects. Of 1082 women who were cultured, 85 (7.8%) were positive for chlamydia. Erythromycin therapy was prescribed for 38 of these women. Nasopharyngeal/conjunctival chlamydia cultures were obtained from 16 infants of culture-positive, treated mothers and 21 infants of culture-positive, untreated mothers. None of the infants born to culture-positive, treated mothers developed infection with chlamydia, while five of 21 infants of untreated mothers (p

UR - http://www.scopus.com/inward/record.url?scp=0022401621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022401621&partnerID=8YFLogxK

U2 - 10.1007/BF01645435

DO - 10.1007/BF01645435

M3 - Article

C2 - 4077268

AN - SCOPUS:0022401621

VL - 13

SP - 263

EP - 266

JO - Infection, Supplement

JF - Infection, Supplement

SN - 0300-8126

IS - 6

ER -